Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M A, Arkans"'
Autor:
D. LaVine, Emily H. Griffith, Lysa P. Posner, Sandra P. Tou, Teresa C. DeFrancesco, Michael W. Nolan, Tracy L. Gieger, M. M. Arkans, Bruce W. Keene, J.A. Myers
Publikováno v:
Journal of Veterinary Cardiology. 19:132-143
Objectives To determine the short-term safety and biologic activity of radiation therapy (RT) for presumptive cardiac hemangiosarcoma in pet dogs. Animals Six dogs with echocardiographic evidence of a right atrial/auricular mass, and hemorrhagic peri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e84a55460ce24d70d7c01d79de0f0e
https://doi.org/10.1016/j.jvc.2016.12.001
https://doi.org/10.1016/j.jvc.2016.12.001
Publikováno v:
Veterinary and comparative oncology. 15(1)
Recent technical advancements in radiation therapy have allowed for improved targeting of tumours and sparing nearby normal tissues, while simultaneously decreasing the risk for medical errors by incorporating additional safety checks into electronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5bd7a0175534baafeb4b43120d42bbc
https://pubmed.ncbi.nlm.nih.gov/26178594
https://pubmed.ncbi.nlm.nih.gov/26178594
Autor:
C M, Mullin, M A, Arkans, C D, Sammarco, D M, Vail, B M, Britton, K R, Vickery, R E, Risbon, J, Lachowicz, K E, Burgess, C A, Manley, C A, Clifford
Publikováno v:
Veterinary and comparative oncology. 14(4)
Sixty-four dogs were treated with single-agent doxorubicin (DOX) for presumptive cardiac hemangiosarcoma (cHSA). The objective response rate (CR + PR) was 41%, and the biologic response rate (CR + PR + SD), or clinical benefit, was 68%. The median pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f9fed54a1227eed5e37292d4eccdf7d
https://pubmed.ncbi.nlm.nih.gov/25524594
https://pubmed.ncbi.nlm.nih.gov/25524594